Company / Revenue per Share
CRESCENT BIOPHARMA, INC. Revenue per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$10.65
FY2025
5-year range
$0.21 / $10.69
FY2021-FY2025
Trend
+1133.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +1133% YoY in FY2025, a notable deviation from the 4-year average annual change of +330%.
Based on SEC 10-K filings.
10.65 in FY2025 with a 10-year CAGR of +48.0%.
Improved from $0.79 to $10.65 over the past 9 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +48.0%
Key checks
Key Insights
- CRESCENT BIOPHARMA, INC.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 1133.2% year-over-year.
- Peak revenue per share was recorded in FY2014.
- Lowest revenue per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.65 | +1133.2% |
| FY2017 | $0.86 | +9.4% |
| FY2016 | $0.79 | +274.2% |
| FY2015 | $0.21 | -98.0% |
| FY2014 | $10.69 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026